Natural products are among the most promising candidates for the development of new drugs. However, due to their structural complexity, they are often difficult to access.

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, announced ...

“We have been continuing to have positive and constructive engagement with the Scottish Funding Council and other stakeholders to develop an alternative pathway towards financial recovery. We have ...

In the classical pathway and lectin pathway, serum C4 levels in patients with NAFLD were higher than those in the control group. In the alternative pathway, serum CFB levels in patients with NAFLD ...

The AA’s business services division is running a webinar this week, designed to help businesses excel on their journey to alternative fuels. Taking place on Friday 21 October at 12:30pm, the event ...

A new oncology alternative payment model (APM) uses treatment and diagnostic pathways embedded in a practice’s electronic heath record (EHR) to manage a “tsunami of data.” It also seeks to go further ...

Overactivation of the alternative pathway of the complement system is associated with the renal diseases atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G). C3 nephritic factors ...